Eating Disorders
Definition and Core Concepts
- Eating disorders (EDs) are psychiatric conditions characterized by severe body dissatisfaction, overvaluation of a thin body ideal, and dysfunctional cognitive and weight control behaviors.
- Anorexia nervosa (AN) typically affects 15 to 19-year-old girls and involves a significant overestimation of body size and shape, coupled with a relentless pursuit of thinness.
- AN presents with an intense fear of becoming fat despite the patient being significantly underweight (often body weight <85% of expected).
- Bulimia nervosa (BN) generally affects 10 to 19-year-old youth (chiefly females) and tends to emerge in later adolescence, sometimes evolving directly from preexisting AN.
- BN is characterized by recurrent episodes of binge eating alternating with inappropriate compensatory behaviors, such as self-induced vomiting, misuse of laxatives or diuretics, fasting, or excessive exercise.
- While AN involves extreme loss of weight, the weight of individuals with BN may fluctuate around a normal to moderately high baseline.
Epidemiology and Patient Profile
| Feature | Anorexia Nervosa | Bulimia Nervosa |
|---|---|---|
| Typical Onset | Early to middle adolescence (15โ19 years). | Later adolescence (10โ19 years). |
| Personality Traits | Above-average intelligence, perfectionist, conflict-avoidant, and risk-aversive. | High impulsivity and frequent features of borderline personality disorder. |
| Psychiatric Comorbidities | High rates of anxiety, obsessive-compulsive symptoms, and emotional "numbness" to starvation. | Pronounced mood swings, depression, posttraumatic stress disorder (PTSD), and higher risk of suicidal ideation. |
DSM-5 Diagnostic Criteria
| Diagnostic Domain | Anorexia Nervosa | Bulimia Nervosa |
|---|---|---|
| Core Behaviors | Restriction of energy intake relative to requirements, leading to significantly low body weight. | Recurrent episodes of binge eating (eating large amounts with a sense of lack of control). |
| Cognitive Features | Intense fear of gaining weight or becoming fat, and severe disturbance in body weight/shape perception. | Self-evaluation is unduly influenced by body shape and weight. |
| Compensatory Acts | Persistent behavior interfering with weight gain despite being at a significantly low weight. | Recurrent inappropriate compensatory behaviors (vomiting, laxatives, exercise) to prevent weight gain. |
| Timeframe/Frequency | Continuous restrictive behaviors causing persistent significantly low weight. | Binge eating and compensatory behaviors occur at least once a week for 3 months. |
| Subtypes | Restricting type (weight loss via fasting/dieting/exercise); Binge-eating/purging type. | N/A (Severity is based on the number of compensatory episodes per week). |
Comparison of Eating and Weight Control Habits
| Habit | Anorexia Nervosa | Bulimia Nervosa |
|---|---|---|
| Dieting and Intake | Rigid adherence to "rules," monotonous "good" food choices, and progressive caloric restriction. | Chaotic eating; frequent dieting interspersed with impulsive, unregulated overeating. |
| Meals and Snacks | Consistent schedule; snacks and meals (especially breakfast) are reduced or eliminated. | Meals are less regimented and often eliminated following a binge-purge episode; snack comfort foods trigger binges. |
| Binge Eating | Absent in the restrictive subtype; an essential feature only in the binge-purge subtype. | An essential, often secretive feature associated with strong shame and guilt. |
| Purging Behaviors | Laxatives may be used to relieve constipation in the restrictive subtype. | Vomiting and laxatives are used frequently as cathartics to reduce the effects of overeating. |
| Exercise | Characteristically obsessive-compulsive, ritualistic, and progressive. | Less predictable; exercise may be avoided entirely or used as a means of purging. |
Physical Signs and Medical Complications
| System | Anorexia Nervosa | Bulimia Nervosa |
|---|---|---|
| General & Metabolic | Cachexia, hypothermia (<35.5ยฐC), cold intolerance, hypoglycemia, and metabolic acidosis/alkalosis. | Weight variable; hypometabolic state less common, but high risk for hypokalemia and electrolyte imbalances. |
| Cardiovascular | Sinus bradycardia, hypotension, orthostasis, and low ECG voltage. | Palpitations, hypovolemia, and dangerous cardiac arrhythmias secondary to electrolyte disturbances. |
| Dermatologic & Hair | Dry and scaly skin, lanugo hair growth on face/body, alopecia, and acrocyanosis. | Calluses over proximal knuckle joints (Russell sign) from digital pharyngeal stimulation. |
| Oral & Gastrointestinal | Early satiety, gastric atony, and severe constipation. | Dental enamel erosion (perimolysis), parotid gland enlargement, subconjunctival hemorrhage, and esophageal ulceration. |
| Endocrine & Skeletal | Amenorrhea (preceding weight loss in up to 30%), delayed puberty, osteopenia, and osteoporosis. | Irregular menses; osteopenia is generally less pronounced than in AN. |
Differential Diagnosis
- Clinicians must rule out medical conditions presenting with high catabolism, such as hyperthyroidism, occult chronic infections, and malignancies.
- Malabsorption syndromes like celiac disease or inflammatory bowel disease can mimic the weight loss of EDs; however, eating in AN causes discomfort due to gastric atony rather than true malabsorption.
- Endocrine disorders such as Addison disease mimic the symptoms of restrictive AN but distinctly present with hyperkalemia and hyperpigmentation.
- Central nervous system anomalies, including craniopharyngiomas or Rathke pouch tumors, may cause weight loss and growth failure but present with signs of increased intracranial pressure.
- Mitochondrial neurogastrointestinal encephalomyopathy (caused by a TYMP gene mutation) presents with gastrointestinal dysmotility, cachexia, and leukoencephalopathy, and is frequently misdiagnosed initially as AN.
- Avoidant/restrictive food intake disorder (ARFID) mimics AN's severe weight loss but lacks any underlying disturbance in body image or drive for thinness; the restriction is driven by sensory aversions or fears of choking.
Management Principles
- The treatment of both AN and BN is ideally provided by an interdisciplinary team comprising a physician, nurse, registered dietitian, and mental health provider.
- The approach should utilize the biopsychosocial model, framing the ED as a "maladaptive coping mechanism" and avoiding placing blame on the patient or the parents.
- Nutritional Rehabilitation (AN):
- The initial goal is to achieve steady weight gain (0.5โ1 lb/week) by increasing energy intake by 100โ200 kcal increments toward a target of approximately 90% of expected body weight.
- Refeeding must proceed carefully, monitoring for refeeding syndrome (characterized by rapid drops in serum phosphorus, magnesium, and potassium) which can precipitate tachycardia, heart failure, and neurologic symptoms.
- Fat content may initially need to be lowered to 15โ20% to accommodate fat phobia, alongside calcium and vitamin D supplementation to address osteopenia.
- Inpatient Medical Hospitalization (AN): Indicated for physiological instability, including a heart rate <50 beats/min, blood pressure <80/50 mm Hg, profound hypothermia (<36.1ยฐC), severe electrolyte disturbances, or body weight <80% of healthy expected weight.
- Psychotherapy:
- Family-Based Treatment: The Maudsley approach is the only evidence-based treatment for AN in children and adolescents; it empowers parents to take an active, nurturing role in restoring their child's eating habits without blame.
- Cognitive-Behavioral Therapy (CBT): Focuses on restructuring thinking errors and establishing adaptive behaviors; it is highly effective in treating both AN and BN.
- Dialectical Behavioral Therapy (DBT): Specifically useful for older adolescents with BN to challenge distorted thoughts and improve emotion regulation and mindfulness.
- Pharmacotherapy:
- Selective Serotonin Reuptake Inhibitors (SSRIs) lack evidence of efficacy for patients with AN who are at a low weight; nutritional restoration remains the primary treatment for depression in AN.
- Conversely, SSRIs (such as fluoxetine at equivalent doses of >60 mg) are considered a standard element of therapy for BN and are highly effective in reducing binge-purge behaviors regardless of the presence of depression.